Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alvotech (ALVO) Capital Expenditures (2022 - 2025)

Historic Capital Expenditures for Alvotech (ALVO) over the last 4 years, with Q3 2025 value amounting to -$18.9 million.

  • Alvotech's Capital Expenditures fell 3694.65% to -$18.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$109.4 million, marking a year-over-year decrease of 9082.77%. This contributed to the annual value of $53.7 million for FY2024, which is 6146.42% up from last year.
  • Latest data reveals that Alvotech reported Capital Expenditures of -$18.9 million as of Q3 2025, which was down 3694.65% from -$13.6 million recorded in Q2 2025.
  • Alvotech's Capital Expenditures' 5-year high stood at -$4.1 million during Q1 2024, with a 5-year trough of -$53.7 million in Q4 2024.
  • In the last 4 years, Alvotech's Capital Expenditures had a median value of -$13.6 million in 2025 and averaged -$18.9 million.
  • In the last 5 years, Alvotech's Capital Expenditures soared by 6407.7% in 2024 and then plummeted by 46984.52% in 2025.
  • Alvotech's Capital Expenditures (Quarter) stood at -$37.9 million in 2022, then grew by 12.27% to -$33.2 million in 2023, then plummeted by 61.46% to -$53.7 million in 2024, then surged by 64.73% to -$18.9 million in 2025.
  • Its Capital Expenditures was -$18.9 million in Q3 2025, compared to -$13.6 million in Q2 2025 and -$23.2 million in Q1 2025.